Clinically validated sequencing panels specifically designed for early-stage cancer detection through liquid biopsy analysis. Supports non-invasive screening and enables identification of disease at earlier stages to improve patient outcomes.
Manufactured by
United Kingdom
Nonacus is a UK-based leader in precision oncology, transforming how cancer is detected and managed. Headquartered in Birmingham and working with scientists and clinicians worldwide, we are building an end-to-end genetic testing workflow designed to make early cancer detection simpler, faster, and more accessible.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
HOLOGIC
China · 1 relevant product
Genes 2Me Private Ltd
India · 5 relevant products
GENETRON HEALTH (BEIJING) CO., LTD
China · 3 relevant products
Burning Rock Dx Co. Ltd.
China · 3 relevant products
shanghai rendu biotechnology co.,ltd.
China · 2 relevant products
BioChain (Beijing) Science & Technology. Inc.
China · 5 relevant products
YouSeq
United Kingdom · 2 relevant products
Rapid Viral Detection Systems
United States · 1 relevant product
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 1 relevant product
Xiamen Micalrun Technology Co.,Ltd
China · 2 relevant products
41 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 84 closest product alternatives
HOLOGIC · China
Advanced molecular testing for genetic markers to inform personalized treatment decisions in breast cancer and other women's health conditions.
Genes 2Me Private Ltd · India
Genomic sequencing panel for cancer-related mutation and biomarker detection. Supports precision oncology treatment planning and selection.
GENETRON HEALTH (BEIJING) CO., LTD · China
Multi-biomarker screening solution for early-stage cancer identification. Analyzes blood samples to detect cancer-associated molecular signatures. Facilitates timely clinical intervention and improved patient outcomes.
Burning Rock Dx Co. Ltd. · China
Next-generation sequencing panel for comprehensive cancer genomic profiling. Identifies mutations, copy number variations, and other genetic alterations to guide personalized treatment strategies.
shanghai rendu biotechnology co.,ltd. · China
A series of RNA-based diagnostic tests designed for early cancer screening and detection. These tests support the identification of cancer biomarkers for early intervention and patient management.
BioChain (Beijing) Science & Technology. Inc. · China
Next-generation sequencing-based multiplex cancer screening panel for simultaneous detection of multiple cancer types. This advanced molecular diagnostic test enables comprehensive cancer risk stratification from single blood samples. The product is in development as part of the company's precision oncology pipeline.
BioChain (Beijing) Science & Technology. Inc. · China
A comprehensive blood-based screening service designed to detect multiple cancer types simultaneously through gene methylation analysis. This service utilizes advanced NGS technology and is available as a clinical testing service.
YouSeq · United Kingdom
A multiplex molecular panel utilizing qPCR and NGS technology for detection of breast cancer-associated genetic markers and mutations. Supports diagnostic confirmation and prognostic assessment for breast cancer management.
Rapid Viral Detection Systems · United States
Point-of-care liquid biopsy platform for rapid cancer detection with 99% accuracy and high sensitivity. Delivers non-invasive screening results in minutes, enabling early diagnosis across multiple cancer types at a lower cost than conventional test kits.
YouSeq · United Kingdom
An NGS-based panel for detection of inherited genetic mutations associated with hereditary cancer syndromes. Enables identification of cancer predisposition for risk stratification and preventive clinical decision-making.
BioChain (Beijing) Science & Technology. Inc. · China
A targeted blood-based early detection service for specific cancer types utilizing gene methylation biomarkers. This clinical testing service is performed by BioChain's certified medical laboratory.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Precision medicine diagnostic test for cancer screening and early detection. Part of the comprehensive oncology testing portfolio covering multiple cancer types.
72 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products